These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 3311225)

  • 1. Lymphocytes and lymphokines in aplastic anemia: pathogenic role and implications for pathogenesis.
    Young NS; Leonard E; Platanias L
    Blood Cells; 1987; 13(1-2):87-100. PubMed ID: 3311225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autoimmune aspects of aplastic anemia.
    Baranski BG; Young NS
    In Vivo; 1988; 2(1):91-4. PubMed ID: 2979824
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lymphokines and hematopoiesis.
    Zoumbos N; Raefsky E; Young N
    Prog Hematol; 1986; 14():201-27. PubMed ID: 2418462
    [No Abstract]   [Full Text] [Related]  

  • 4. [Aplastic anemia].
    Klingemann HG; Havemann K
    Dtsch Med Wochenschr; 1984 Nov; 109(47):1816-21. PubMed ID: 6389074
    [No Abstract]   [Full Text] [Related]  

  • 5. "Myelophrenia": its contribution to the management of aplastic anemia.
    Nathan DG
    Prog Clin Biol Res; 1984; 148():xxi-xxx. PubMed ID: 6379655
    [No Abstract]   [Full Text] [Related]  

  • 6. Immunologic mechanisms in aplastic anemia.
    Finlay JL; Ershler WB; Shahidi NT
    Am J Pediatr Hematol Oncol; 1980; 2(3):223-32. PubMed ID: 7001943
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Special Education: Aplastic Anemia.
    Teramura M; Mizoguchi H
    Oncologist; 1996; 1(3):187-189. PubMed ID: 10387986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of interferon-gamma and tumor necrosis factor-alpha in bone marrow T cells and their levels in bone marrow plasma in patients with aplastic anemia.
    Dubey S; Shukla P; Nityanand S
    Ann Hematol; 2005 Sep; 84(9):572-7. PubMed ID: 15815907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aplastic anemia: pathophysiology and management.
    Rothberg H
    J Med Soc N J; 1985 Jun; 82(6):457-62. PubMed ID: 3874287
    [No Abstract]   [Full Text] [Related]  

  • 10. Possible pathogenic mechanisms in aplastic anemia.
    Boggs DR; Boggs SS
    Transplant Proc; 1978 Mar; 10(1):125-30. PubMed ID: 635987
    [No Abstract]   [Full Text] [Related]  

  • 11. Immunologic aspects of aplasia.
    Speck B; Cornu P; Sartorius J; Nissen C; Groff P; Burri HP; Jeannet M
    Transplant Proc; 1978 Mar; 10(1):131-4. PubMed ID: 345551
    [No Abstract]   [Full Text] [Related]  

  • 12. [Pressing problems of hypoplastic (aplastic) anemias].
    Faĭnshteĭn FE; Turbina NS; Liubimova LS
    Probl Gematol Pereliv Krovi; 1979 May; 24(5):3-7. PubMed ID: 377275
    [No Abstract]   [Full Text] [Related]  

  • 13. Aplastic anemia following infectious mononucleosis: possible immune etiology.
    Shadduck RK; Winkelstein A; Zeigler Z; Lichter J; Goldstein M; Michaels M; Rabin B
    Exp Hematol; 1979 May; 7(5):264-71. PubMed ID: 314384
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T-derived colony-inhibiting activity (Td/CIA) in aplastic anemia (SAA) and in normal donors.
    Bacigalupo A; Podestá M; Frassoni F; Piaggio G; Raffo MR; Repetto M; Van Lint MT; Marmont AM
    Prog Clin Biol Res; 1984; 148():173-83. PubMed ID: 6379658
    [No Abstract]   [Full Text] [Related]  

  • 15. [Immunological mechanisms in aplastic anemia. II. Clinical data suggesting the role of immunologic disorders in the etiology of aplastic anemia: studies in vitro].
    Rupniewska ZM; Dmoszyńska-Giannopoulos A
    Przegl Lek; 1982; 39(10):667-74. PubMed ID: 6218514
    [No Abstract]   [Full Text] [Related]  

  • 16. T cells and myeloid progenitors in patients with severe aplastic anemia (SAA).
    Bacigalupo A; Piaggio G; Figari O; Frassoni F; Podesta M; Marmont AM
    Blood Cells; 1988; 14(2-3):485-96. PubMed ID: 3265880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acquired aplastic anemias: pathophysiology and treatment.
    Rappeport JM; Nathan DG
    Adv Intern Med; 1982; 27():547-90. PubMed ID: 7041554
    [No Abstract]   [Full Text] [Related]  

  • 18. Excessive production of tumor necrosis factor-alpha by bone marrow T lymphocytes is essential in causing bone marrow failure in patients with aplastic anemia.
    Hara T; Ando K; Tsurumi H; Moriwaki H
    Eur J Haematol; 2004 Jul; 73(1):10-6. PubMed ID: 15182332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of aplastic anemia.
    Gordon-Smith EC
    Prog Clin Biol Res; 1984; 148():335-41. PubMed ID: 6379671
    [No Abstract]   [Full Text] [Related]  

  • 20. [Immunopathogenesis of aplastic anemia].
    Speck B
    Internist (Berl); 1979 Oct; 20(10):502-5. PubMed ID: 389876
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.